Sanofi ADR (SNYN)
BMV
724.00
0.00 (0.00%)
Closed
Oct 7, 2026
Day's Range
724.00724.00
52 wk Range
724.00955.00
Financial Statements - SNYN - Sanofi ADR
Revenue
46.71B▼ 94.9%
Net Income
7.85B▼ 93.2%Net Margin 16.8%
EBITDA
15.77B▼ 94.2%
Free Cash Flow
7.21B▼ 94.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 46.71B | 909.81B | 46.44B | 45.38B | 39.17B | 37.36B |
| Cost of Goods | 13.04B | 271.28B | 14.23B | 13.69B | 12.25B | 12.15B |
| Gross Profit | 33.66B | 638.53B | 32.20B | 31.69B | 26.92B | 25.21B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 9.59B | 194.38B | 10.39B | 11.88B | 9.14B | 7.89B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -3.29B | -45.27B | -2.60B | -1.17B | -979M | 6.22B |
| Pre Tax Income | 6.17B | 137.60B | 7.15B | 10.42B | 7.79B | 13.77B |
| Income Tax | 1.04B | 24.73B | 1.60B | 2B | 1.55B | 1.80B |
| Net Income | 7.85B | 115.41B | 5.43B | 8.48B | 6.27B | 12.33B |
| EPS Basic | 3.2 | 2.295 | 2.155 | 3.345 | 2.485 | 4.905 |
| EPS Diluted | 3.2 | 2.295 | 2.15 | 3.33 | 2.475 | 4.88 |
| Basic Shares Outstanding | 2.44B | 51.41B | 116.94M | 116.96M | 117.01M | 117.12M |
| Diluted Shares Outstanding | 2.44B | 51.41B | 116.94M | 116.96M | 117.01M | 117.12M |
| Ebit | 6.80B | 152.99B | 7.81B | 10.88B | 8.18B | 14.21B |
| Ebitda | 15.77B | 271.94B | 15.20B | 15.47B | 12.51B | 11.79B |
| Net Income Continuous Operations | 4.93B | 112.91B | 5.40B | 8.37B | 6.22B | 12.29B |
| Minority Interests | -38M | -58M | -36M | -113M | -56M | -36M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
